Tehran University of Medical Sciences

Science Communicator Platform

Share By
Recent Advances in Gene Therapy-Based Cancer Monotherapy and Synergistic Bimodal Therapy Using Upconversion Nanoparticles: Structural and Biological Aspects Publisher Pubmed



Sohrabi M1 ; Babaei Z1 ; Haghpanah V1 ; Larijani B1 ; Abbasi A1 ; Mahdavi M1
Authors

Source: Biomedicine and Pharmacotherapy Published:2022


Abstract

In accordance with human genetics and genomics advances over the past years, it can be found that cancer is created through a somatic aberration in the host genome. Accordingly, researchers use therapeutic methods in genetic manipulation to discover the possible cure for the disease. In combination with traditional cancer treatments, gene therapy (GT) is essential in future cancer therapy. The development of powerful nanocarriers for targeted, controlled, and efficient intracellular delivery of therapeutic biomolecules that increase pharmacokinetics indicates that the development of GT is highly dependent on nanotechnology. Among nanocarriers, upconversion nanoparticles (UCNPs) have become the focus of great attention in the realm of inorganic nanomedicines following the strategy of “diagnosis for treatment” due to their outstanding features including safety, deep penetration of near-infrared (NIR) light into tissue, and reduction of unfavorable side effects of NIR-triggered therapies. Moreover, various individual therapies can be intelligently combined into a single nanotranostic system based on a UCNP platform for multimodal synergistic treatment. Given that the preparation of multifunctional nanomaterials is a prerequisite for the realization of cancer treatment, especially synergistic therapies, the recognition of the main components of advanced nanoparticles can help researchers in choosing the proper platform for cancer treatment. In view of this, the main goal of this review is to highlight the latest advances in the construction and application of upconversion nanoparticles as carriers for gene delivery and gene editing in cancer monotherapy and bimodal synergistic therapy, with an emphasis on the structural and biological aspects of these studies. © 2022
1. Targeted Cancer Therapy: Review Article, Tehran University Medical Journal (2018)
2. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
3. Gene Therapy: A Promising Approach for Breast Cancer Treatment, Cell Biochemistry and Function (2022)
Experts (# of related papers)
Other Related Docs
4. Gene Therapy Clinical Trials, Where Do We Go? an Overview, Biomedicine and Pharmacotherapy (2022)
10. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
11. The Horizon of Gene Therapy in Modern Medicine: Advances and Challenges, Advances in Experimental Medicine and Biology (2020)
12. Metallic Nanoparticles for the Modulation of Tumor Microenvironment; a New Horizon, Frontiers in Bioengineering and Biotechnology (2022)
18. Nanoparticles-Mediated Crispr/Cas9 Delivery: Recent Advances in Cancer Treatment, Journal of Drug Delivery Science and Technology (2020)